In the frontier field of integrating life sciences and artificial intelligence, AI life omics technology is undergoing a leapfrog development from interdisciplinary exploration to systematic integration and application, becoming the core engine driving biomedical research and precision medicine innovation. With the explosive growth of global life science data and breakthroughs in computing technology, China's AI life omics industry has risen rapidly and gradually joined the ranks of global technological innovation leaders.
The '2024 AI Life Omics Industry Market Research Report' comprehensively analyzes the industry ecosystem landscape, systematically elaborates on the definition, technical characteristics, development history, and industrial chain structure of AI life omics, and conducts in-depth analysis from multiple dimensions such as technological evolution, policy environment, market pattern, and future opportunities. AI life omics technology has entered a new stage of multimodal data fusion and intelligent decision-making. Through innovative tools such as high-throughput sequencing, single-cell analysis, and AI agents, it has built a full-chain capability from basic research to clinical translation, becoming the core technical infrastructure for life science laboratories, pharmaceutical R&D centers, and medical institutions.
